As shown in Figure 7, tracking of T-cell proliferation showed that both BM and TB-MSCs inhibited the allo-immune reaction of CD4+ or CD8+ T-cells to comparable levels, indicating that TB-MSCs can also exert a comparable immune-modulating potential as BM-MSCs. The gene discussed is CD4; the disease is tuberculosis.